Skip to main content

Your search for “Novel Treatment” returned 433 results

UC San Diego’s ‘Proof-of-Concept’ Awards Move Campus Health Innovations to Market

July 13, 2018

Nine teams of UC San Diego students, faculty and other researchers who have developed novel innovations that could improve various aspects of health care, have been awarded proof-of-concept awards designed to help bring their campus inventions to commercial use.

UC San Diego Named Stem Cell “Alpha Clinic”

October 23, 2014

In a push to further speed clinical development of emerging stem cell therapies, Sanford Stem Cell Clinical Center at UC San Diego Health System was named today one of three new “alpha clinics” by the California Institute for Regenerative Medicine, the state’s stem cell agency.

UC San Diego Part of New Effort to Fight Autoimmune Disorders

September 25, 2014

The Division of Rheumatology, Allergy and Immunology at University of California, San Diego School of Medicine has been named a key site in a national, multi-institution, multi-year $41.6 million program to speed drug discovery, development, diagnostics and therapies for patients with autoimmune disorders, primarily rheumatoid arthritis (RA) and lupus erythematosus,…

New NIH Network Revolutionizes Stroke Clinical Research

December 13, 2013

…three core features of stroke research and care: prevention, treatment and recovery. The regional coordinating centers (RCCs), working with nearby satellite facilities, will span the country and have teams of researchers representing every stroke-related medical specialty, with the primary goal of bringing new therapies and strategies to the stroke community…

New Injectable Hydrogel Encourages Regeneration and Improves Functionality After a Heart Attack

February 20, 2013

University of California, San Diego bioengineers have demonstrated in a study in pigs that a new injectable hydrogel can repair damage from heart attacks, help the heart grow new tissue and blood vessels, and get the heart moving closer to how a healthy heart should. The results of the study…

Embryonic Development Protein Active in Cancer Growth

March 5, 2012

A team of scientists at the University of California, San Diego Moores Cancer Center has identified a novel protein expressed by breast cancer cells – but not normal adult tissues – that could provide a new target for future anti-cancer drugs and treatments.

Joint Resolution: A Link Between Huntington’s Disease and Rheumatoid Arthritis

May 15, 2018

Using new analytic tools, researchers at University of California San Diego School of Medicine and the Icahn School of Medicine at Mount Sinai have decoded the epigenetic landscape for rheumatoid arthritis (RA), a common autoimmune disease that affects more than 1.3 million Americans.

By Blocking Protein, Researchers Keep Brain Tumors from Repairing Themselves

February 28, 2019

Researchers at the San Diego Branch of the Ludwig Institute for Cancer Research at UC San Diego report inhibiting activity of a specific protein in glioblastomas boosts their sensitivity to radiation, improving treatment prospects for one of the most common and aggressive forms of brain cancer.

Neuronal Structures Associated with Learning and Memory Sprout In Response to Novel Molecules

April 11, 2016

Chemists at the University of California San Diego have designed a set of molecules that promote microscopic, anatomical changes in neurons associated with the formation and retention of memories. These drug candidates also prevent deterioration of the same neuronal structures in the presence of amyloid-beta, a protein fragment that accumulates…

Kidneys Aren’t Harmed When Significantly Lowering Blood Pressure

October 22, 2018

Using a novel biomarker panel to track and measure kidney function, researchers at University of California San Diego School of Medicine and University of California San Francisco School of Medicine report that lowering systolic blood pressure to less than 120 mm Hg does not damage the kidney organ itself. Instead,…

Category navigation with Social links